GlassScriptPhysician profile
Frederick Greiner Barr
NPI 1184620122
$27,006.17
in general payments reported to CMS, 2019-2025
81 companies · $83.99 in 2025
The $83.99 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,712 · 2020: $3,831 · 2021: $4,638 · 2022: $4,686 · 2023: $5,036 · 2024: $4,018 · 2025: $83.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,039 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,038.97 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,810.02 | 2019-2024 | Calquence, Enhertu, Lynparza |
| Janssen Biotech, INC. | $1,778.51 | 2019-2024 | Rybrevant, Darzalex, Erleada |
| E.R. Squibb & Sons, L.L.C. | $1,421.07 | 2019-2024 | Opdivo, Krazati, Eliquis |
| Novartis Pharmaceuticals Corporation | $1,375.93 | 2019-2024 | Kisqali, Piqray |
| Merck Sharp & Dohme LLC | $1,304.06 | 2019-2024 | Keytruda, Lynparza, Welireg |
| Pfizer INC. | $1,255.97 | 2019-2024 | |
| Genzyme Corporation | $1,058.44 | 2019-2024 | |
| Lilly USA, LLC | $986.14 | 2019-2024 | Verzenio, Jaypirca, Retevmo |
| Genentech USA, INC. | $881.15 | 2019-2024 | Lunsumio, Polivy, Venclexta |
| Amgen INC. | $871.42 | 2019-2023 | Nplate, Xgeva, Lumakras |
| Seagen INC. | $814.00 | 2019-2023 | Adcetris, Tivdak, Tukysa |
| Incyte Corporation | $654.48 | 2019-2024 | Jakafi, Monjuvi, Pemazyre |
| Daiichi Sankyo INC. | $627.51 | 2019-2025 | Enhertu, Injectafer |
| Taiho Oncology, INC. | $621.18 | 2019-2023 | |
| Eisai INC. | $611.57 | 2019-2024 |
Show all 81 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $611.23 | 2019-2024 | Opdualag, Reblozyl, Pomalyst |
| Takeda Pharmaceuticals U.S.A., INC. | $591.21 | 2019-2024 | Alunbrig, Ninlaro, Fruzaqla |
| Pharmacyclics LLC, An Abbvie Company | $501.28 | 2019-2023 | Imbruvica, Epkinly |
| Astellas Pharma US INC | $457.66 | 2019-2024 | Padcev, Xospata |
| Puma Biotechnology, INC. | $455.68 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $454.14 | 2019-2024 | |
| Tersera Therapeutics LLC | $374.82 | 2019-2024 | Xermelo, Zoladex |
| Emd Serono, INC. | $364.15 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $337.45 | 2019-2023 | |
| Abbvie INC. | $327.64 | 2019-2024 | |
| Rigel Pharmaceuticals, INC. | $320.79 | 2019-2024 | Tavalisse, Rezlidhia |
| Regeneron Healthcare Solutions, INC. | $320.27 | 2021-2024 | Libtayo |
| Gilead Sciences, INC. | $288.03 | 2019-2024 | Trodelvy |
| Pharmacosmos Therapeutics INC. | $267.40 | 2021-2024 | Monoferric, Cosela |
| Exelixis INC. | $260.02 | 2019-2024 | Cabometyx |
| Secura Bio, INC. | $250.00 | 2021 | |
| Ipsen Biopharmaceuticals, INC | $245.22 | 2019-2024 | Onivyde, Somatuline Depot |
| Glaxosmithkline, LLC. | $244.92 | 2020-2024 | Zejula, Jemperli |
| Coherus Oncology, INC. | $226.10 | 2021-2025 | Udenyca |
| Myriad Genetic Laboratories, INC. | $208.68 | 2020-2024 | Precisetumor, Mychoice Cdx |
| Array Biopharma INC | $201.80 | 2020-2024 | Braftovi, Mektovi, Lorbrena |
| Blueprint Medicines Corporation | $196.92 | 2020-2024 | Ayvakit |
| Karyopharm Therapeutics INC. | $191.32 | 2020-2024 | Xpovio |
| Beigene USA, INC. | $183.89 | 2020-2023 | Brukinsa |
| Pharmaessentia USA Corporation | $181.64 | 2022-2024 | Besremi |
| Foundation Medicine, INC. | $167.53 | 2019-2022 | |
| Mirati Therapeutics, INC. | $167.49 | 2023-2024 | Krazati |
| Kite Pharma, INC. | $165.81 | 2021-2025 | Yescarta |
| Alexion Pharmaceuticals, INC. | $165.57 | 2019-2024 | Ultomiris |
| Clovis Oncology, INC. | $143.71 | 2019-2021 | |
| Aveo Pharmaceuticals, INC. | $128.59 | 2021-2024 | Fotivda |
| Eusa Pharma (US) LLC | $120.23 | 2020-2022 | |
| Heron Therapeutics, INC. | $108.95 | 2019-2023 | Sustol |
| Agios Pharmaceuticals, INC. | $98.92 | 2019-2021 | |
| Spectrum Pharmaceuticals INC. | $96.58 | 2019-2024 | Rolvedon |
| Stemline Therapeutics INC. | $95.06 | 2023-2024 | Orserdu |
| Adaptive Biotechnologies Corporation | $84.97 | 2022-2024 | Clonoseq |
| Cti Biopharma Corp. | $79.42 | 2022-2023 | Vonjo |
| Kyowa Kirin, INC. | $79.05 | 2019-2024 | Poteligeo |
| Sobi, INC | $78.87 | 2022-2024 | |
| Sanofi-Aventis U.S. LLC | $75.99 | 2020 | |
| Janssen Scientific Affairs, LLC | $73.94 | 2019 | |
| Dendreon Pharmaceuticals LLC | $73.57 | 2019-2020 | |
| G1 Therapeutics, INC. | $70.61 | 2022-2023 | Cosela |
| Myovant Sciences INC. | $70.24 | 2021-2022 | |
| Acrotech Biopharma INC. | $66.15 | 2022-2024 | Beleodaq |
| Adc Therapeutics America, INC. | $64.46 | 2022 | |
| Sun Pharmaceutical Industries INC. | $58.78 | 2019-2020 | |
| Tactile Systems Technology INC | $52.16 | 2019-2023 | Flexitouch Plus, Entre Plus |
| Morphosys, US INC. | $49.38 | 2023-2024 | Monjuvi |
| Janssen Pharmaceuticals, INC | $47.10 | 2019-2024 | Xarelto |
| Epizyme, INC. | $44.37 | 2021 | |
| Deciphera Pharmaceuticals INC. | $42.62 | 2021 | |
| Ge Healthcare | $40.66 | 2021 | |
| Servier Pharmaceuticals LLC | $35.29 | 2021-2022 | |
| Tesaro, INC. | $25.53 | 2019 | |
| Global Blood Therapeutics, INC. | $24.56 | 2022 | |
| Jazz Pharmaceuticals INC. | $22.98 | 2019 | |
| Blue Earth Diagnostics | $22.01 | 2021 | |
| Partner Therapeutics, INC. | $21.17 | 2020 | |
| Tg Therapeutics, INC. | $20.91 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $19.80 | 2019 | |
| Springworks Therapeutics, INC. | $19.49 | 2024 | Ogsiveo |
| Roche Diagnostics Corporation | $18.78 | 2019 | |
| Mylan Institutional INC. | $17.70 | 2020 | |
| Sumitomo Pharma America, INC. | $13.46 | 2023 | Orgovyx |
Drugs and devices associated with these payments
Enhertu $422Keytruda $322Opdivo $318Imbruvica $314Calquence $234Lenvima $223Kisqali $211Sarclisa $204Adcetris $201Udenyca $195Krazati $194Padcev $192Rybrevant $190Lynparza $188Verzenio $180Polivy $178Lunsumio $178Monjuvi $174Jakafi $173Pluvicto $170Jaypirca $164Venclexta $148Darzalex $140Braftovi $137Besremi $132Onivyde $128Columvi $126Injectafer $125Yescarta $118Scemblix $116Rezlidhia $115Tavalisse $115Xofigo $113Erleada $113Monoferric $110Ibrance $109Lonsurf $108Inqovi $108Somatuline Depot $106Mektovi $105Xermelo $105Lutathera $104Oxbryta $101Elrexfio $99.23Retevmo $98.13Piqray $96.17Xpovio $95.56Orserdu $95.06Epkinly $93.72Alunbrig $87.99Cabometyx $85.73Nubeqa $84.12Tasigna $82.91Ninlaro $80.95Tukysa $78.41Tivdak $78.03Libtayo $77.46Trodelvy $75.24Fotivda $74.59Pemazyre $73.34Nplate $72.95Xgeva $72.95Ayvakit $72.17Vitrakvi $70.90Stivarga $70.90Opdualag $70.01Lorbrena $67.79Rolvedon $67.18Jevtana $66.70Ultomiris $63.92Vonjo $63.75Carvykti $58.33Welireg $54.77Doptelet $54.32Precisetumor $52.21Gazyva $51.22Clonoseq $50.02Brukinsa $49.23Tecentriq $48.36Lumakras $47.73Mychoice Cdx $47.64Xalkori $47.37Kyprolis $45.17Blincyto $45.17Sustol $44.02Imfinzi $43.80Fruzaqla $43.38Poteligeo $43.03Beleodaq $41.26Reblozyl $41.21Pomalyst $40.47Elitek $39.71Cosela $39.34Mekinist $37.65Bosulif $36.01Fabhalta $32.78Iclusig $31.74Tecvayli $31.54Talvey $31.54Zoladex $30.69
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frederick Barr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.